VIM3‐ARA C: An effective salvage regimen in refractory or recurrent aggressive non hodgkin's lymphoma. A report on 18 cases
暂无分享,去创建一个
[1] J. Anderson,et al. Phase II trial of ifosfamide and mesna in previously treated patients with non‐hodgkin's lymphoma: Cancer and leukemia group b study 8552 , 2006, Hematological oncology.
[2] P. Colombat,et al. The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] K. Sullivan,et al. Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] H. Lazarus,et al. The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation , 1990 .
[5] M. Caligiuri,et al. High‐dose cytosine arabinoside in relapsed and refractory non‐Hodgkin's lymphoma. Limited role as a single agent , 1989, Cancer.
[6] H. Earl,et al. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Weisenburger,et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. , 1989, Blood.
[8] K. Sullivan,et al. Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] B. Coiffier,et al. LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] L. Nadler,et al. Autologous bone marrow transplantation in the treatment of malignant lymphoma and Hodgkin's disease. , 1988, Seminars in hematology.
[11] S. Jagannath,et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). , 1988, Blood.
[12] K. Anderson,et al. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. , 1987, The New England journal of medicine.
[13] J. Armitage,et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. , 1987, The New England journal of medicine.
[14] W. Velasquez,et al. Results of MIME salvage regimen for recurrent or refractory lymphoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] F. Cabanillas,et al. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. , 1982, Blood.
[16] E. Frei,et al. Dose: a critical factor in cancer chemotherapy. , 1980, The American journal of medicine.
[17] R. Fisher,et al. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. , 1977, The American journal of medicine.